Sphera Funds Management Ltd. Cytokinetics Inc Call Options Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$51.22 - $60.16 $2.56 Million - $3.01 Million	50,000 New	50,000 $2.64 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $784,896 - $2.44 Million	-29,200 Reduced 44.92%	35,800 $2.99 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $1.91 Million - $2.38 Million	65,000 New	65,000 $1.91 Million
Q3 2017 Nov 09, 2017	BUY	$12.0 - $15.0 $1.2 Million - $1.5 Million	100,000	100,000 $1.45 Million

406

125M

4.61M

2.46M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.7B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.